Evidence map›Paper›PMID 24039544›Full record

ArticleEuropean journal of organic chemistry2012

Perylenequinones: Isolation, Synthesis, and Biological Activity.

Carol A Mulrooey, Erin M O'Brien, Barbara J Morgan, Marisa C Kozlowski

Abstract read
In one paragraph

Article in European journal of organic chemistry, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Article
  2. Interplay betweenMycology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Volatiles ofSynthetic and systems biotechnology · 2023
    Article
  9. Article
  10. Review
  11. Article
  12. Journal of fungi (Basel, Switzerland) · 2023
    Article
  13. Fungal perylenequinones.Mycological progress · 2022
    Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Fungal Pigments and Their Roles Associated with Human Health.Journal of fungi (Basel, Switzerland) · 2020
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Carol A MulrooeyDepartment of Chemistry, Roy and Diana Vagelos Laboratories, University of Pennsylvania, Philadelphia, Pennsylvania 19104-6323, USA.
Erin M O'Brien
Barbara J Morgan
Marisa C Kozlowski

Funding

Synthesis of Novel Anticancer AgentsR01CA109164 · NCI · UNIVERSITY OF PENNSYLVANIA · PI KOZLOWSKI, MARISA C · 2004 to 2007
$807k
SYNTHESIS OF NOVEL ANTICANCER AGENTSR56CA109164 · NCI · UNIVERSITY OF PENNSYLVANIA · PI KOZLOWSKI, MARISA C · 2009 to 2009
$198k
NCI NIH HHS R01 CA109164NCI NIH HHS R56 CA109164
6 · The paper itself

Abstract

The perylenequinones are a novel class of natural products characterized by pentacyclic conjugated chromophore giving rise to photoactivity. Potentially useful light-activated biological activity, targeting protein kinase C (PKC), has been identified for several of the natural products. Recently discovered new members of this class of compound, as well as several related phenanthroperylenequinones, are reviewed. Natural product modifications that improve biological profiles, and avenues for the total synthesis of analogs, which are not available from the natural product series, are outlined. An overview of structure/function relationships is provided.

Indexed as

BinaphtholChiral BiarylNatural ProductsPerylenequinonePhotodynamic Therapy

Identifiers

PMID24039544
PMCPMC3770481

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.